FDA Adverse Event Injury Summary report: N

UNKN GENESIS II TOTAL KNEE TIB BASEPLATE

MDR report key: 19103049 · Received April 14, 2024

Report

Report Number
1020279-2024-00752
Event Type
Injury
Date Received
April 14, 2024
Date of Event
June 28, 2023
Report Date
May 23, 2024
Manufacturer
SMITH & NEPHEW, INC.
Product Code
JDG
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IT
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

INTERNAL COMPLAINT REFERENCE NUMBER: (B)(4). SECTION H6 (HEALTH EFFECT - CLINICAL CODE) WAS CORRECTED.

Additional Manufacturer Narrative · 0

INTERNAL COMPLAINT REFERENCE: CASE (B)(4). ¿THIS COMPLAINT WAS OPENED BY SMITH+NEPHEW TO DOCUMENT A PATIENT COMPLICATION IDENTIFIED THROUGH A REVIEW OF CLINICAL EVIDENCE FROM LITERATURE SOURCES THAT INCLUDES REFERENCE TO THE USE OF A SMITH+NEPHEW PRODUCT. THE REPORTED ISSUE(S) RELATE TO KNOWN INHERENT PROCEDURAL RISKS THAT ARE APPROPRIATELY DOCUMENTED IN OUR RISK FILES. SMITH+NEPHEW WILL CONTINUE TO MONITOR TRENDS IN ACCORDANCE WITH OUR POST-MARKET SURVEILLANCE PROCESS AND TAKE NECESSARY ACTION AS REQUIRED IF ANTICIPATED SEVERITY AND/OR OCCURRENCE RATES ARE EXCEEDED. SMITH+NEPHEW HAS NO REASON TO SUSPECT THAT THE PRODUCT FAILED TO MEET ANY SPECIFICATIONS AT THE TIME OF MANUFACTURE. BASED ON OUR REVIEW OF ALL CURRENTLY AVAILABLE INFORMATION, WE ARE UNABLE TO CONFIRM A RELATIONSHIP BETWEEN THE REPORTED EVENT AND THE DEVICE OR IDENTIFY A DEFINITIVE ROOT CAUSE. HOWEVER, AS THE USE OF OUR PRODUCT CANNOT BE EXCLUDED AS A POTENTIAL CAUSE OR CONTRIBUTORY FACTOR TO THE REPORTED ISSUE, WE ARE CONSERVATIVELY SUBMITTING THIS REPORT IN ACCORDANCE WITH APPLICABLE REGULATIONS. IF ADDITIONAL INFORMATION BECOMES AVAILABLE THAT ALTERS THE CONCLUSIONS OF THIS REPORT, A FOLLOW-UP REPORT WILL BE SUBMITTED AS REQUIRED. DOI: DOI.ORG/10.3390/JCM12134356. CARULLI, C., INNOCENTI, M., TAMBASCO, R., PERRONE, A., & CIVININI, R. (2023). TOTAL KNEE ARTHROPLASTY IN HAEMOPHILIA: LONG-TERM RESULTS AND SURVIVAL RATE OF A MODERN KNEE IMPLANT WITH AN OXIDIZED ZIRCONIUM FEMORAL COMPONENT. JOURNAL OF CLINICAL MEDICINE, 12(13), 4356.

Description of Event or Problem · 0

IT WAS REPORTED THAT ON LITERATURE REVIEW "TOTAL KNEE ARTHROPLASTY IN HAEMOPHILIA: LONG-TERM RESULTS AND SURVIVAL RATE OF A MODERN KNEE IMPLANT WITH AN OXIDIZED ZIRCONIUM FEMORAL COMPONENT", 1 PATIENT, DUE TO RECURRENT BLEEDINGS, HAD AN EARLY MECHANICAL LOOSENING OF THE FEMORAL AND TIBIAL COMPONENT 4 YEARS AFTER A TKA PROCEDURE USING GENESIS LL IMPLANT SYSTEM. THIS ISSUE WAS SOLVED WITH A REVISION SURGERY WITH CEMENTLESS STEMS AND A HIGHER CONSTRAINT IMPLANT. NO FURTHER INFORMATION IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
793414 UNKN GENESIS II TOTAL KNEE TIB BASEPLATE PROSTHESIS, HIP, FEMORAL COMPONENT, CEMENTED, METAL JDG SMITH & NEPHEW, INC. UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Required Intervention